Coccidioidal meningitis. The use of amphotericin B in treatment. 1961

H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN

Amphotericin B is the first agent to alter favorably the course of coccidioidal meningitis. The morbidity and toxicity of the drug are at present its chief limiting factors. Although no cures were obtained in a series of 11 cases, significant remissions usually followed a course of therapy. Comparison with similar groups showed a significant prolongation of life in adequately treated cases.

UI MeSH Term Description Entries
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D003047 Coccidioidomycosis Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN. Coccidioides Infection,Coccidioides posadasii Infection,Coccidioidomycosis Infection,Coccidioides immitis Infection,San Joaquin Valley Fever,Valley Fever,Coccidioides Infections,Coccidioides immitis Infections,Coccidioides posadasii Infections,Coccidioidomycoses,Coccidioidomycosis Infections,Infection, Coccidioides,Infection, Coccidioides immitis,Infection, Coccidioides posadasii,Infection, Coccidioidomycosis,Valley Fevers
D005659 Fungicides, Industrial Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. Industrial Fungicides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D016921 Meningitis, Fungal Meningitis caused by fungal agents which may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts. Fungal Meningitis,Pachymeningitis, Fungal,Fungal Meningitides,Fungal Pachymeningitides,Fungal Pachymeningitis,Meningitides, Fungal,Pachymeningitides, Fungal
D019369 Life The state that distinguishes organisms from inorganic matter, manifested by growth, metabolism, reproduction, and adaptation. It includes the course of existence, the sum of experiences, the mode of existing, or the fact of being. Over the centuries inquiries into the nature of life have crossed the boundaries from philosophy to biology, forensic medicine, anthropology, etc., in creative as well as scientific literature. (Random House Unabridged Dictionary, 2d ed; Dr. James H. Cassedy, NLM History of Medicine Division)

Related Publications

H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
September 1973, California medicine,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
September 1973, California medicine,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
April 1988, Archives of internal medicine,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
August 1964, California medicine,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
October 1959, The American journal of medicine,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
June 2018, Mycopathologia,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
January 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
March 1975, The Western journal of medicine,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
January 1995, Archives of internal medicine,
H E EINSTEIN, and C W HOLEMAN, and L L SANDIDGE, and D H HOLDEN
January 1983, Pediatric infectious disease,
Copied contents to your clipboard!